
Justice RS Endlaw of the Delhi High Court has reserved judgment on the petitions filed by pharma companies challenging the Health Ministry’s ban on 344 FDC (Fixed Dose Combination) drugs.
We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.